EDIT vs WAB · rev $32.3M vs P/E 38, rev $10.39B
Editas Medicine Inc (EDIT) versus Westinghouse Air Brake Technologies Corp (WAB) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Westinghouse Air Brake Technologies Corp (WAB) is a railroads company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported WAB revenue for 2024-12-31 was $10.39B. Net income was $1.07B. Revenue was up 7.3% from 2023-12-31 to 2024-12-31. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
EDIT currently screens at market cap $375.2M. WAB currently screens at market cap $46.13B and trailing P/E 38.4.
Not investment advice. Open the EDIT and WAB stock pages for the full models.
Not investment advice.